Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 64451-64500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05948592
Bacteriophage Therapy TP-102 in Patients With Diabetic Foot Infection
PHASE2Recruiting
80 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors10 locations
NCT05784012
Two-cohort Study of Niraparib and Dostarlimab Plus (Chemo)RadIotherapy in Locally-Advanced Head and Neck Squamous Cell Carcinoma
PHASE1/PHASE2Recruiting
34 participants
Started: Nov 8, 2023 · Completed: Mar 31, 2029
1 condition3 sponsors5 locations
NCT06004115
Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
PHASE4Recruiting
165 participants
Started: Nov 8, 2023 · Completed: Nov 30, 2027
6 conditions3 sponsors1 location
NCT06267859
Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children
EARLY_PHASE1Recruiting
110 participants
Started: Nov 8, 2023 · Completed: Jan 30, 2034
2 conditions1 sponsor1 location
NCT06223802
Biodex Training in Hemodialysis Females With Osteopenia
NARecruiting
58 participants
Started: Nov 8, 2023 · Completed: Mar 8, 2024
1 condition1 sponsor1 location
NCT06178198
Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma
PHASE2Recruiting
30 participants
Started: Nov 8, 2023 · Completed: Nov 30, 2026
1 condition1 sponsor1 location
NCT06652568
Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection
NARecruiting
500 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2025
2 conditions6 sponsors5 locations
NCT06130566
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
PHASE3Active, not recruiting
601 participants
Started: Nov 8, 2023 · Completed: Nov 12, 2025
1 condition1 sponsor148 locations
NCT06147999
Impact of a Biophoton Therapy on Patients With Brain Disorders
NARecruiting
80 participants
Started: Nov 8, 2023 · Completed: Nov 8, 2026
1 condition1 sponsor1 location
NCT05540899
Testing the Safety of Giving a Standard Dose of Radiation Over a Shorter Period of Time for Patients Who Had Surgery for Intermediate-Risk Head and Neck Cancer
PHASE1Active, not recruiting
14 participants
Started: Nov 8, 2023 · Completed: Nov 30, 2028
5 conditions2 sponsors1 location
NCT05913544
Short Integrative And Neurocognitive Therapy For Young Adults With Borderline Personality Disorder
NARecruiting
74 participants
Started: Nov 8, 2023 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT06498310
Retrospective Study of Invasive Fungal Infections With Filamentous Fungi in Heart Transplant Patients
N/ARecruiting
100 participants
Started: Nov 8, 2023 · Completed: Nov 8, 2025
1 condition1 sponsor1 location
NCT06020209
CCT for Comprehensive Risk Stratification Following STEMI
NARecruiting
200 participants
Started: Nov 8, 2023 · Completed: Apr 30, 2026
1 condition5 sponsors3 locations
NCT06071091
Permanent Intracranial Stenting for Acute Ischemic Stroke Related to a Refractory Large Vessel Occlusion
NAActive, not recruiting
346 participants
Started: Nov 8, 2023 · Completed: Aug 1, 2027
1 condition1 sponsor13 locations
NCT06193577
Effect of Phaseolus Vulgaris L. Dry Extract on the Modulation of Weight and Metabolic Parameters
NARecruiting
60 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2025
1 condition3 sponsors1 location
NCT05662423
Preventing Childbirth-Related PTSD With Expressive Writing
NARecruiting
136 participants
Started: Nov 8, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT06238687
A Study of STRO-002 in Chinese Adults With Epithelial Ovarian Cancer and Other Advanced Malignant Solid Tumors
PHASE1/PHASE2Recruiting
132 participants
Started: Nov 8, 2023 · Completed: Dec 30, 2027
1 condition2 sponsors1 location
NCT05909150
Hypertonic Saline Solution to Prevent Acute Kidney Injury After Heart Transplantation
PHASE2Recruiting
74 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2026
2 conditions1 sponsor1 location
NCT05604560
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
PHASE2Active, not recruiting
25 participants
Started: Nov 8, 2023 · Completed: Sep 30, 2026
1 condition3 sponsors2 locations
NCT06376565
Improving Colonoscopy Surveillance for Patients with High Risk Colon Polyps
NARecruiting
1,680 participants
Started: Nov 8, 2023 · Completed: Nov 30, 2027
1 condition2 sponsors1 location
NCT06361615
Effect of a Dual-task Intervention Program on Physical and Cognitive Function
NAActive, not recruiting
24 participants
Started: Nov 8, 2023 · Completed: Apr 5, 2024
2 conditions1 sponsor1 location
NCT05953038
LSD Occupancy of the Serotonin 2A Receptor in the Human Brain
EARLY_PHASE1Active, not recruiting
40 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05925803
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
PHASE3Recruiting
306 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2027
2 conditions1 sponsor198 locations
NCT04778046
Pulmonary Hypertension SOLAR
PHASE2Recruiting
30 participants
Started: Nov 8, 2023 · Completed: Dec 30, 2025
3 conditions1 sponsor1 location
NCT05803382
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
PHASE1Recruiting
30 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2026
5 conditions1 sponsor22 locations
NCT06027333
Self-efficacy and Well-being of Patients With Fibrotic Interstitial Lung Disease
N/ARecruiting
80 participants
Started: Nov 8, 2023 · Completed: Aug 30, 2024
6 conditions4 sponsors2 locations
NCT06105749
Biennial CEM in Women With a Personal History of Breast Cancer
NARecruiting
1,500 participants
Started: Nov 8, 2023 · Completed: Apr 30, 2031
4 conditions2 sponsors6 locations
NCT06195150
Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
N/ARecruiting
3 participants
Started: Nov 8, 2023 · Completed: Oct 31, 2025
2 conditions1 sponsor1 location
NCT06034184
Enhancing Mass Casualty Triage Through Virtual Reality Simulation
NARecruiting
100 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2024
4 conditions3 sponsors1 location
NCT05982730
SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease
NARecruiting
15 participants
Started: Nov 8, 2023 · Completed: Jul 31, 2026
1 condition1 sponsor1 location
NCT05900284
Safety and Feasibility of Metformin for Sepsis Induced AKI
PHASE2Enrolling by invitation
80 participants
Started: Nov 8, 2023 · Completed: Mar 1, 2026
4 conditions3 sponsors1 location
NCT06072183
A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2
PHASE3Active, not recruiting
1,571 participants
Started: Nov 8, 2023 · Completed: Jul 30, 2027
2 conditions1 sponsor230 locations
NCT06017791
Management of Excess Gingival Display Using Tunnel Technique With 3D Designed PEEK Shell: A Case Series
NARecruiting
10 participants
Started: Nov 8, 2023 · Completed: Feb 28, 2026
1 condition1 sponsor1 location
NCT06699420
Qishenyiqi Dripping Pill for Coronary Microvascular Disease
PHASE4Recruiting
162 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor3 locations
NCT06084988
A Study to Evaluate the Safety of Human Allogeneic Bone-Marrow-Derived Mesenchymal Stromal Cell Product StromaForte for the Treatment of Knee Osteoarthritis
PHASE1/PHASE2Recruiting
12 participants
Started: Nov 8, 2023 · Completed: Apr 7, 2025
1 condition2 sponsors1 location
NCT05978089
Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome(MET STUDY)
PHASE4Recruiting
120 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT06010303
A Study to Evaluate LBL-007 in Combination With Tislelizumab Plus Chemotherapy in Participants With Unresectable Locally Advanced or Metastatic Esophageal Squamous Cell Carcinoma
PHASE2Active, not recruiting
118 participants
Started: Nov 8, 2023 · Completed: May 23, 2026
3 conditions1 sponsor38 locations
NCT06023706
Study Evaluating the Analgesic Efficacy of Capsaicin 8% Patches in Chronic Coccygodynia.
PHASE3Recruiting
188 participants
Started: Nov 8, 2023 · Completed: Jun 8, 2027
3 conditions1 sponsor6 locations
NCT06411197
Exploration of Gait Biomechanics and Muscle Pain of the Lower Extremity
NARecruiting
36 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06032156
Ketone Dose and Cerebral Blood Flow Study
NARecruiting
20 participants
Started: Nov 8, 2023 · Completed: Aug 31, 2024
2 conditions1 sponsor1 location
NCT05904717
Effect of PXS-4728A on Microglia Activation in Participants With Isolated Rapid Eye Movement Sleep Behaviour Disorder
PHASE2Active, not recruiting
40 participants
Started: Nov 8, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor3 locations
NCT06247215
Building Resilience for Advance Care Planning (ACP) in Chinese Americans
N/ARecruiting
121 participants
Started: Nov 8, 2023 · Completed: Dec 31, 2025
1 condition4 sponsors1 location
NCT06120712
A Phase Ⅰb Study on Autologous GC101 TIL Injection for the Treatment of Advanced Melanoma (MIZAR-002)
PHASE1/PHASE2Recruiting
20 participants
Started: Nov 8, 2023 · Completed: Jul 6, 2025
5 conditions1 sponsor1 location
NCT06119308
Brief Cognitive Behavioral Therapy to Enhance Benzodiazepine Deprescribing
NAActive, not recruiting
20 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2025
3 conditions3 sponsors1 location
NCT05968716
Addressing Unmet Social Needs Among Hospitalized Children
NAActive, not recruiting
50 participants
Started: Nov 8, 2023 · Completed: May 31, 2025
6 conditions2 sponsors1 location
NCT06121102
Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain
NARecruiting
60 participants
Started: Nov 8, 2023 · Completed: Apr 1, 2024
5 conditions1 sponsor1 location
NCT06116942
Magnetic Brain Stimulation and Computer-based Motor Training for Rehabilitation After Stroke
NARecruiting
24 participants
Started: Nov 8, 2023 · Completed: Sep 19, 2027
1 condition2 sponsors1 location
NCT06224205
Digital Detection of Dementia (D Cubed) Studies: D3
NARecruiting
3,150 participants
Started: Nov 8, 2023 · Completed: Nov 8, 2025
1 condition2 sponsors1 location
NCT05829070
Improving Health Insurance Literacy Among Young Adult Cancer Survivors
NAEnrolling by invitation
300 participants
Started: Nov 8, 2023 · Completed: Mar 31, 2028
1 condition3 sponsors1 location
NCT06148402
Fruquintinib Plus Camrelizumab and Capecitabine as Salvage Therapy After Progression on FOLFOXIRI-based First-line Treatment in Patients With Unresectable/Metastatic Colorectal Cancer
PHASE2Recruiting
30 participants
Started: Nov 8, 2023 · Completed: Jun 30, 2026
1 condition1 sponsor1 location